© 2004 by Oxford University Press
© 2004 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Alfred G. Knudson
Jr., M.D., Ph.D., of Fox Chase Cancer Center in
Philadelphia, has been named winner of a 2004 Kyoto Prize, a lifetime
achievement award given to those who have "contributed significantly to
mankind's benefit." Knudson, who is being honored for his role in
establishing the theory of tumor suppressor genes, will receive a cash gift of
about $450,000 (50 million yen), the gold Kyoto Prize medal, and a diploma at
the Kyoto Prize ceremony in Kyoto, Japan, on November 10.
|
Four researchers have been recognized by the General Motors Cancer
Research Foundation for their contributions to cancer research.
Thomas Kelly, M.D., Ph.D., director of the Sloan-Kettering Institute in New York, and Bruce Stillman, Ph.D., president and chief executive officer of Cold Spring Harbor Laboratory in Cold Spring Harbor, N.Y., have been awarded the Alfred P. Sloan Jr. Prize for their contributions to the understanding of the biochemistry and regulation of DNA replication.
Robert Langer, Sc.D., professor of chemical and biomedical engineering at the Massachusetts Institute of Technology in Cambridge, Mass., was honored with the Charles F. Kettering Prize for the development of sustained-release drug delivery systems for the treatment of cancer.
Charles J. Sherr, M.D., Ph.D., the Herrick Foundation co-chair of genetics and tumor biology at St. Jude Children's Research Hospital in Memphis, Tenn., was awarded the Charles S. Mott Prize for the discovery and characterization of key genes and proteins that control cell division and are frequently involved in the development of cancer.
Five cancer researchers have won the 2004 Prince of Asturias Award
for Technical and Scientific Research: Judah Folkman, M.D., head of the
Department of Surgical Research at Children's Hospital in Boston and professor
of cellular biology at Harvard Medical School in Cambridge, Mass.; Tony
Hunter, Ph.D., a professor in the molecular and cellular biology
laboratory at the Salk Institute in La Jolla, Calif.; Joan Massagué,
Ph.D., head of the Department of Cell Biology and Genetics and chairman of
the cancer biology and genetics program at the Memorial Sloan-Kettering Cancer
Center in New York; Bert Vogelstein, M.D., professor of oncology at
Johns Hopkins University School of Medicine in Baltimore; and Robert A.
Weinberg, Ph.D., a founding member of the Whitehead Institute for
Biomedical Research and professor of biology at the Massachusetts Institute of
Technology in Cambridge, Mass.
Tak Mak, Ph.D., has been named director of the new Institute
for Breast Cancer Research at Princess Margaret Hospital in Toronto. Mak is a
senior scientist with the hospital's research arm, the Ontario Cancer
Institute, and a professor at the University of Toronto.
The White House has appointed five new members to the National
Cancer Advisory Board (NCAB) for 6-year terms. The board advises the Secretary
of Health and Human Services and the Director of the National Cancer Institute
about the institute's activities. The new members are: John E. Niederhuber,
M.D., professor of surgery and oncology at the University of Wisconsin
Medical School in Madison, and a current NCAB member who will also serve as
chairmandesignate for a 2-year term; Kathryn Giusti, president of the
Multiple Myeloma Research Foundation; Diana M. Lopez, Ph.D., professor
of microbiology and immunology at the University of Miami School of Medicine,
in Miami; Carolyn D. Runowicz, M.D., professor of obstetrics and
gynecology and director of the UConn Comprehensive Cancer Center of the
University of Connecticut Health Center in Farmington; and Daniel Von Hoff,
M.D., director of the Cancer Therapeutics Program at the Arizona Health
Science Center in Tucson.
Thomas Jefferson University Hospital in Philadelphia, Pa., has made
two new appointments.
Scott Goldstein, M.D., has been named director of colon and rectal surgery at the hospital. Goldstein is also assistant professor of surgery at Jefferson Medical College of Thomas Jefferson University.
David F. Silver, M.D., has joined the hospital's Division of Gynecologic Oncology and has also been appointed assistant professor of obstetrics and gynecology at Jefferson Medical College. Silver previously served as director of the Division of Gynecologic Oncology at the Eastern Virginia Medical School in Norfolk, Va.
The Roswell Park Cancer Institute in Buffalo, N.Y., has made two new
faculty appointments.
Sergio Onate, Ph.D., has been appointed to the departments of urologic oncology and pharmacology and therapeutics. Onate previously served as assistant professor in the Department of Cell Biology and Physiology at the University of Pittsburgh.
Susan Nowell, Ph.D., joined the Division of Cancer Prevention and Population Sciences. Nowell comes to the institute from the University of Arkansas for Medical Sciences in Little Rock.
Edward Chu, M.D., professor of internal medicine and
pharmacology at the Yale University School of Medicine in New Haven, Conn.,
has been named chief of the medical oncology section at the Yale Cancer
Center.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||